Record profits. Job openings. Shareholders making money. It's not what you might think in Michigan, home to the country's highest unemployment rate, but a century-old company is in robust health thanks to achy, thifty Americans.

A UBS analyst said Wednesday that medical technology stocks are trading at attractive prices, and raised his ratings or price targets on nine of them.

Healthcare reform will bring slightly greater pricing pressure but larger volume for medical technology firms, says Steve Macmillan, CEO of Stryker.

Knee replacement surgery is expensive but worth the cost, especially if performed by experienced surgeons, U.S. researchers said on Monday.